
MorphoSys AG MOR
Geschäftsbericht 2023
hinzugefügt 27.12.2025
MorphoSys AG Anteile 2011-2026 | MOR
Anteile Jährlich MorphoSys AG
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 33.4 M | 126 M | 126 M | 125 M | - | - | - | - | - | - | - |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 126 M | 33.4 M | 103 M |
Anteile anderer Aktien in der Pharmaeinzelhändler
| Name | Anteile | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Acer Therapeutics
ACER
|
15.8 M | - | 2.71 % | $ 14 M | ||
|
I-Mab
IMAB
|
187 M | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
219 M | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
1.08 K | - | -10.17 % | $ 12.2 K | ||
|
Biophytis SA
BPTS
|
118 M | - | -13.47 % | $ 169 M | ||
|
Aeglea BioTherapeutics
AGLE
|
78.2 M | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
45 M | - | - | $ 26.5 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.58 M | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
80.5 M | - | -18.52 % | $ 27.3 M | ||
|
Black Diamond Therapeutics
BDTX
|
55 M | $ 2.38 | -3.64 % | $ 131 M | ||
|
ARCA biopharma
ABIO
|
16.8 M | - | 1052.0 % | $ 415 M | ||
|
Acorda Therapeutics
ACOR
|
1.24 M | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
12.1 M | - | 4.01 % | $ 150 M | ||
|
Adverum Biotechnologies
ADVM
|
19.8 M | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
75 M | - | - | - | ||
|
AIkido Pharma
AIKI
|
6.18 M | - | 1.93 % | $ 17.4 M | ||
|
Akero Therapeutics
AKRO
|
67.1 M | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
34.4 M | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
19.2 M | - | -0.23 % | $ 916 M | ||
|
Alector
ALEC
|
103 M | $ 2.1 | -13.79 % | $ 216 M | ||
|
Allena Pharmaceuticals
ALNA
|
68 M | - | 3.16 % | $ 1.9 M | ||
|
Aileron Therapeutics
ALRN
|
17.9 M | - | 10.36 % | $ 9.8 M | ||
|
AlloVir
ALVR
|
5.01 M | - | 4.14 % | $ 49.1 M | ||
|
Alpine Immune Sciences
ALPN
|
33.4 M | - | - | $ 2.17 B | ||
|
Aeterna Zentaris
AEZS
|
115 M | - | 5.93 % | $ 314 M | ||
|
Ampio Pharmaceuticals
AMPE
|
810 K | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
38.8 M | - | - | $ 10.1 M | ||
|
Aravive
ARAV
|
36.4 M | - | -13.39 % | $ 1.45 M | ||
|
Aptose Biosciences
APTO
|
699 K | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
67.7 M | - | -39.0 % | $ 4.57 M | ||
|
Athira Pharma
ATHA
|
38.5 M | - | - | $ 269 M | ||
|
Aridis Pharmaceuticals
ARDS
|
18.8 M | - | 17.91 % | $ 11.1 M | ||
|
Altimmune
ALT
|
71 M | $ 4.2 | -2.67 % | $ 298 M | ||
|
Arena Pharmaceuticals
ARNA
|
60.8 M | - | -6.81 % | $ 3.04 B | ||
|
CureVac N.V.
CVAC
|
186 M | - | - | $ 867 M | ||
|
Avenue Therapeutics
ATXI
|
1.3 M | - | -52.27 % | $ 4.45 M | ||
|
Athersys
ATHX
|
224 M | - | 3.77 % | $ 22.4 M | ||
|
Axcella Health
AXLA
|
54.4 M | - | -16.42 % | $ 249 M | ||
|
AstraZeneca PLC
AZN
|
1.42 B | - | - | $ 96.9 B | ||
|
AVEO Pharmaceuticals
AVEO
|
32.7 M | - | - | $ 521 M | ||
|
Atreca
BCEL
|
38.6 M | - | -11.76 % | $ 5.79 M | ||
|
AVROBIO
AVRO
|
44.3 M | - | 1083.1 % | $ 745 M | ||
|
Apellis Pharmaceuticals
APLS
|
126 M | $ 20.61 | -1.67 % | $ 2.6 B | ||
|
Agenus
AGEN
|
358 K | $ 3.33 | - | $ 1.19 M | ||
|
Ayala Pharmaceuticals
AYLA
|
15.4 M | - | - | $ 7.46 M | ||
|
Agios Pharmaceuticals
AGIO
|
58 M | $ 28.87 | -4.5 % | $ 1.67 B | ||
|
bluebird bio
BLUE
|
110 M | - | - | $ 546 M | ||
|
Brickell Biotech
BBI
|
5.39 M | - | -5.38 % | $ 6.06 M | ||
|
Advaxis
ADXS
|
6.02 M | - | -9.65 % | $ 45.9 M |